These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6467653)

  • 21. Sensory system involvement in infantile spinal muscular atrophy.
    Marshall A; Duchen LW
    J Neurol Sci; 1975 Nov; 26(3):349-59. PubMed ID: 127019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Werdnig-Hoffmann disease.
    Penchaszadeh V; Williams D
    Birth Defects Orig Artic Ser; 1971 Feb; 7(2):98. PubMed ID: 5173131
    [No Abstract]   [Full Text] [Related]  

  • 23. Spinal roots in Werdnig-Hoffmann disease.
    Ghatak NR
    Acta Neuropathol; 1978 Jan; 41(1):1-7. PubMed ID: 636832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glial bundles of nerve roots in Werdnig-Hoffmann disease.
    Chou SM
    Ann Neurol; 1980 Jul; 8(1):79-82. PubMed ID: 7406450
    [No Abstract]   [Full Text] [Related]  

  • 25. [A case of Werdnig-Hoffmann disease in a newborn infant].
    Guarniere J; Inferrera C; Di Prima C; Barresi G
    Pediatria (Napoli); 1977 Dec; 85(4):625-44. PubMed ID: 349495
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical picture, pathogenesis and geneology of hereditary progressive spinal muscular atrophies].
    Nesterov LN; Sushcheva GP; Viatkina SIa; Novikova NP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):321-30. PubMed ID: 6326437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Werdnig-Hoffmann disease and chronic distal spinal muscular atrophy with apparent autosomal dominant inheritance.
    Boylan KB; Cornblath DR
    Ann Neurol; 1992 Sep; 32(3):404-7. PubMed ID: 1416812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal muscular atrophy type II. A separate genetic and clinical entity from type I (Werdnig-Hoffmann disease) and type 3 (Kugelberg-Welander disease).
    Fried K; Emery AE
    Clin Genet; 1971; 2(4):203-9. PubMed ID: 5146579
    [No Abstract]   [Full Text] [Related]  

  • 29. [The efficacy of guanidine hydrochloride in the treatment of Werdnig-Hoffmann disease (author's transl)].
    Steinböck H; Binder H; Gerstenbrand F; Pilz E; Maida E
    Wien Klin Wochenschr; 1977 Apr; 89(8):269-72. PubMed ID: 857433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Werdnig-Hoffmann spinal amyotrophy in twins].
    Mazaeva IV; Lipovetskaia NG; Balashova EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1491-5. PubMed ID: 4795172
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic investigations on chronic forms of infantile and juvenile spinal muscular atrophy.
    Hausmanowa-Petrusewicz I; Zaremba J; Borkowska J; Prot J
    J Neurol; 1976 Oct; 213(4):335-46. PubMed ID: 62033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurogenic muscular atrophy of infancy with prolonged survival. The variable course of Werdnig-Hoffmann Disease.
    Munsat TL; Woods R; Fowler W; Pearson CM
    Brain; 1969 Mar; 92(1):9-24. PubMed ID: 5774034
    [No Abstract]   [Full Text] [Related]  

  • 33. [Proximal spinal muscular atrophy--a contribution to the question of intrafamiliar variability and the genetics of the disease (author's transl)].
    Kollmann D; Murken JD; Förster C
    Monatsschr Kinderheilkd (1902); 1974 Jun; 122(6):327-30. PubMed ID: 4849530
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ultrastructural findings and characterization of isoenzymes in the muscle in case of Werdnig-Hoffmann disease].
    Ferreli A; Cao A; Onnis C
    Arch De Vecchi Anat Patol; 1967 Dec; 50(3):629-44. PubMed ID: 5634345
    [No Abstract]   [Full Text] [Related]  

  • 35. Animal model of human disease. Infantile spinal muscular atrophy, Werdnig-Hoffman disease. Animal model: Hereditary neuronal abiotrophy in Swedish Lapland dogs.
    Sandefeldt E; Cummings JF; de Lahunta A; Björck G; Krook LP
    Am J Pathol; 1976 Mar; 82(3):649-52. PubMed ID: 1258980
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial trisomy 9p and spinal muscular atrophy: clinical, cytogenetic and embryological findings.
    Tolksdorf M; Kunze J; Gross-Selbeck G; Sperling K; Wegner RD; Wieczorek V; Vogel M
    Eur J Pediatr; 1977 Aug; 126(1-2):13-27. PubMed ID: 902660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrastructural aspects of muscle and nerve in Werdnig-Hoffmann disease.
    Szliwowski HB; Drochmans P
    Acta Neuropathol; 1975; 31(4):281-96. PubMed ID: 1155040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infantile spinal muscular atrophy (SMA) and multiple congenital bone fractures in sibs: a lethal new syndrome.
    Borochowitz Z; Glick B; Blazer S
    J Med Genet; 1991 May; 28(5):345-8. PubMed ID: 1865475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharyngo-laryngeal deficit in the acute form of infantile spinal muscular atrophy (Werdnig-Hoffmann disease).
    Grünebaum M; Nutman J; Nitzan M
    Pediatr Radiol; 1981; 11(2):67-70. PubMed ID: 7301447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cases of familial Werdnig-Hoffmann syndrome, including a pair of concordant monozygotic twins (a case from the Eugenic Consultation Clinic)].
    GEDDA L; DEL PORTO G; DEL PORTO-MERCURIA
    Acta Genet Med Gemellol (Roma); 1962 Apr; 11():113-23. PubMed ID: 13897442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.